小児性セプティック関節炎に関するオンラインの患者教育資料は,推奨読解レベルを超えています:読解性の分析
Nicholas J Pettinelli1,2, Madison C Blackwell2, Mark Schwartz3
1Trauma Institute, Saint Francis Health System, Tulsa, USA.
Cureus
|February 16, 2026
まとめ
小児性性関節炎に関する患者教育資料は,しばしば推奨読解レベルを超えており,家族にとって重要な整形外科の緊急情報へのアクセスを妨げています. これらの材料の改善は,健康の平等のために不可欠です.
科学分野:
- 整形外科 整形外科
- 小児医学は,小児科の医学である.
- 健康に関するコミュニケーション
背景:
- 小児性性関節炎は,迅速な診断と治療を必要とする重要な整形外科の緊急事態です.
- アクセシブルな患者教育資料 (PEMs) は,この状態に関する情報を求める家族にとって不可欠です.
- 既存の整形外科PEMは,推奨グレードレベルを超えて,読解性の課題をしばしば提示します.
研究 の 目的:
- 小児性性関節炎のオンラインPEMの読みやすさを評価する.
- これらの材料が,既定の読みやすさガイドラインと整合しているかを評価する.
- トップランクにある米国の小児整形外科病院のコンテンツを分析するために.
主な方法:
- 関連するPEMについて,米国のトップ25の小児整形外科病院のウェブサイトを検索しました.
- 8つの標準化された可読度メトリクスを用いて,合格する12のPEMを分析した.
- Flesch-Kincaid Grade Level (FKGL) と病院ランキングが相関している.
主要な成果:
- 平均読解性は10.6級レベルであり,推奨される6年生のレベルを大幅に上回りました.
- PEMのいずれも,推奨される読みやすさ基準を満たしていない.
- 7つのPEMは8年生の読解レベル以上で,5つのPEM (41.7%) は8年生の読解レベル以下で,しばしば第三者のコンテンツを使用しています.
結論:
- トップクラスの小児整形外科病院の有意な部分では,セプティック関節炎のPEMが提供されていません.
- 小児性性関節炎に関するオンラインで入手可能な情報は,推奨される読みやすさレベルを頻繁に超えています.
- シンプルな言語,外部レビュー,またはAI支援編集を実装することで,素材のアクセシビリティと健康の公平性を向上させることができます.
関連する概念動画
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
01:21Health Literacy
5.4K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.4K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
323
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
01:29Drug Dosing: Infants and Children
337
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
256
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
335
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335